Biopreserving Pathogens: Promise & Peril

Area of Science:

• Microbiology and Infectious Diseases
• Biotechnology and Biopreservation
• Regulatory Science and Public Health

Background:

• Biopreservation technologies for infectious organisms are advancing.
• Careful risk-benefit analysis is crucial for developing these technologies.
• Existing regulatory frameworks require examination for pathogen biopreservation.

Purpose of the Study:

• To review the U.S. regulatory landscape for pathogen biopreservation.
• To analyze the benefits and risks associated with biopreserving infectious organisms.
• To explore regulatory oversight responsibilities in the context of biosafety, biosecurity, and biocontainment.

Main Methods:

• Literature review of U.S. regulations and guidelines.
• Case study analysis of two significant pathogens: Cryptosporidium and Plasmodium.
• Risk-benefit assessment framework applied to biopreservation scenarios.

Main Results:

• The U.S. regulatory framework for pathogen biopreservation is complex.
• Biopreservation of Cryptosporidium and Plasmodium presents specific biosafety and biosecurity challenges.
• Oversight responsibilities are distributed across multiple agencies.

Conclusions:

• Effective regulation is essential for safe pathogen biopreservation.
• Balancing innovation with robust safety and security measures is paramount.
• Further clarification of oversight is needed for emerging biopreservation technologies.